A factorial randomised controlled trial to evaluate efficacy and safety of adding aspirin plus omega-3 or colchicine as repurposed treatments to enhance chronic obstructive pulmonary disease (COPD) exacerbation resolution and reduce recurrent exacerbations.
National Institute for Health and Care Research
· United Kingdom · £202.2M GBP
We use cookies to keep your session secure, remember your preferences, and analyse site traffic with Google Analytics.
By continuing to use GrantFunds you agree to our
Privacy Policy
and
Terms of Use.